awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35892171-241ABD63-D8D5-4415-B86C-FFB11D3C553E
Q35892171-241ABD63-D8D5-4415-B86C-FFB11D3C553E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35892171-241ABD63-D8D5-4415-B86C-FFB11D3C553E
Ximelagatran: a new antithrombotic option in atrial fibrillation.
P2860
Q35892171-241ABD63-D8D5-4415-B86C-FFB11D3C553E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35892171-241ABD63-D8D5-4415-B86C-FFB11D3C553E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a47ea73418b8f0f81173aa8da3e44b1561feb7dc
P2860
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.